COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

UCSD's Gary Firestein Receives Jane Wyman Humanitarian Award

 

October 25, 2010  |  

Gary S. Firestein, MD, professor of medicine, dean and associate vice chancellor of Translational Medicine and director of the Clinical and Translational Research Institute at the University of California, San Diego School of Medicine, has been named the 2010 recipient of the prestigious Jane Wyman Humanitarian Award. This award recognizes Firestein’s “affiliation with the Arthritis Foundation and its mission, and his extraordinary leadership in rheumatology and philanthropy in the community. “


Gary S. Firestein

The award will be presented at the foundation’s Commitment to a Cure Gala at the Beverly Wilshire Hotel in Beverly Hills on November 1.  Past recipients of the Jane Wyman Humanitarian Award have included Victoria Principal; Sarah Purcell; Kathy Ireland; William Friedkin, Academy Award winning director of “The French Connection” and “The Exorcist;”  Los Angeles Dodger Manager, Joe Torre; and Academy Award winning legend, Al Pacino.

Firestein is considered leading expert in the field of rheumatoid arthritis, a disabling and chronic disease affecting some 2.1 million Americans. His research focuses on the pathogenesis of rheumatoid arthritis and mechanisms of inflammation and his studies have played a pivotal role in the development of the highly effective drugs to treat this crippling disease.

# # #

Media Contact:  Debra Kain, ddkain@ucsd.edu, 619-543-6163




Media Contact

Share This Article


Related News

7/1/2022
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
6/29/2022
UC San Diego Health study identifies the main job stressors contributing to physician suicides.
6/21/2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
6/15/2022
A UC San Diego study describes the short- and long-term neurological symptoms of SARS-CoV-2 infection, and identifies a new group of COVID-19 long-haulers with advanced motor and cognitive symptoms.



Follow Us